EUCTR2011-001205-27-NL进行中（未招募）不适用
The effect of fibrate therapy in two patients with neutral lipid storage disease with myopathy (NLSDM). - Fibrate Trail
未提供0 个研究点开始时间: 2011年7月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patients need to have NLSDM; as there are only 6 patients in the world and 2 of them in the Netherlands, we aim to include both patients.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •This is more a case study, therefore we don't have any exclusion criteria.
研究者
相似试验
已完成
4 期
The effect of fibrate therapy in two patients with neutral lipid storage disease with myopathy (NLSDM).NL-OMON37985niversiteit Maastricht10
已完成
不适用
Additional treatment with fibrates for patients treated with pitavastatin under ordinary medical practice for hypertriglyceridemia in JapaCombined dyslipidemiaJPRN-UMIN000001828Chu-NET60
已完成
不适用
Comparison of therapeutic effects of Fenofibrate and Gemfibrozil on Lipid in patients with DiabetesIRCT201401096710N4Research deputy of Tabriz University of Medical Sciences60
已完成
3 期
Evaluation of efficacy and safety of Fenofibrate in COVID-19 patientsIRCT20220612055149N1Artesh University of Medical Sciences70
招募中
不适用
Anti-fibrotic treatment in patients with idiopathic pulmonary fibrosis:A cohort studyidiopathic pulmonary fibrosisJPRN-UMIN000020392niversity of Occupational and Environmental Health, Japan100